What is Splose?
Founded in 2018, Splose emerged from a deep-seated understanding of the operational inefficiencies plaguing the Allied Health sector. By transitioning from web development to specialized practice management software, the company has addressed critical pain points regarding system reliability and speed. Splose distinguishes itself through a user-centric design philosophy, backed by a leadership team with extensive experience in both clinical operations and large-scale workforce management. The platform serves as a digital backbone for providers, enabling them to reduce administrative burden and focus on delivering high-quality client support. As the company scales, it continues to leverage its engineering talent to refine its product suite, aiming to set a new industry standard for efficiency and usability in healthcare technology.
How much funding has Splose raised?
Splose has raised a total of $46M across 1 funding round:
Series A
$46M
Series A (2026): $46M with participation from Spectrum Equity and Athletic Venture Advisors
Key Investors in Splose
Spectrum Equity
Spectrum Equity is a growth-oriented investment firm providing capital and strategic support to companies operating within the information economy.
Athletic Venture Advisors
Athletic Venture Advisors provides business insights and investment opportunities, focusing on connecting stakeholders with resources in the athletic and performance sectors.
What's next for Splose?
With this major enterprise-level funding, Splose is poised to enter a phase of aggressive market expansion and product maturation. The strategic allocation of capital will likely focus on enhancing the platform's automation capabilities and expanding its footprint within the Allied Health ecosystem. By prioritizing the development of robust, scalable infrastructure, the company aims to solidify its position as a market leader. Future growth initiatives will likely involve deepening the integration of its software with broader healthcare networks, thereby increasing the value proposition for its growing user base. As Splose continues to scale, the focus remains on maintaining the agility of a startup while delivering the reliability required by large-scale clinical enterprises.
See full Splose company page
